Sunday, April 17

  Pre-Symposium Workshop

• Mario Chiong Lay, University of Chile, Santiago, Chile
• Leonardo Arriagada Rivas, San Juan de Dios Hospital, Santiago, Chile
• Betzabé Rubio Lara, Institute of Cancer Therapies Providencia, Santiago, Chile
• Paul Sessink, Exposure Control Sweden AB, Bohus-Björkö, Sweden
• Johan Vandenbroucke, Ghent University Hospital, Ghent, Belgium

  Opening Plenary: Access to Cancer Medicines: Global Disparities Deserve Global Attention

• Julie Torode, Union for International Cancer Control (UICC), Geneva, Switzerland

Monday, April 18

  Plenary: Novel Immunotherapy for Melanoma: Mechanisms, Outcomes, and Future Strategies

• R. Donald Harvey, Winship Cancer Institute of Emory University, Atlanta, GA, USA

  Plenary: Clinical Impact and Recent Outcomes of Immunotherapy in Solid Tumours: Is it the Pathway for Cancer Cure?

• Christian Caglevic, Fundación Arturo López Pérez, Santiago, Chile

  Clinical 1A
  Solid Tumor Updates

  Lung Cancer
  Evelyn Handel 

  Breast Cancer 
  Kellie Jones Weddle

 Research 1B
 Research with Complementary
 Alternative Medications in Oncology
 Judith Smith

  Clinical 2A
  Antiemetic Updates 

  Olanzapine
   Alex Chan

  New NK-1 Antagonists
  Ivonne Flores 

  Fundamental 2B
  Pharmacovigilance Plan for
  Biologics and Biosimilar
  Antibodies: Is It Really Useful? 

  Juan Roldán Saelzer

 Research 2C 
 Epigenetic Bases
 of Gastric Cancer: From
 Pathogenesis to the
 Potential Identification
 of New Targets for
 Prevention and Treatment 

  Alejandro Corvalan

  Clinical 3A
  Pediatrics/Adolescents/Young 
  Adults Update

  Description of Tools
  Pharmaceutical Care
  in Acute Lymphoblastic
  Leukemia (Pharmacogenomics)
  Hospital Pediatric Experience
  Chilean Program Associated
  with Antineoplastic Drugs (PINDA)  
  Jorge Morales

  Update on Paediatric
  Bone Tumours
  John Wiernikowski

  Fundamental 3B
  USP 800 Implementation 
  and Practical Considerations

  USP 800 Implementation:
  Considerations Across
  Practice Settings 
  Rowena Schwartz 

  USP 800 Implementation:
  Consider a Case of the
  National Cancer Center
  Hospital East, Japan
  Shinya Suzuki

  Fundamental 3C
  Education, Competency
  and Mentorship

  Barry Goldspiel, 
  Judith Smith

  Fundamental 4A
  Oral Medication Adherence
  and Management in Oncology 
  Steve Stricker 

  Strategies to Improve Oral
  Medication Adherence in
  Oncology
  Harbans Dhillon

  Research 4B
  Investigational Agents Update

  Rowena Schwartz, R. Donald Harvey

  Clinical 4C
  Oncology Patients and
  Special Circumstances 
  
  Incidence of Drug-
  Induced Liver Injury in
  Patients Hospitalized
  at The Instituto 
  Nacional de
  Enfermedades
  Neoplasicas Lima
  Martha Estacio

  Cancer in Pregnancy
  Peter Gilbar

Tuesday, April 19

  Plenary: PD-L1 Test - Where Are We Today?

• Cristian Ortiz-Villalon, Karolinska University Hospital, Stockholm, Sweden

  Plenary: Dermatologic Toxicities: The Superficial Side of Targeted Therapies  

• Milan J. Anadkat, Washington University School of Medicine, St. Louis, MO, USA

  Clinical 5A
 Hematological Cancer Updates 

 Chronic Lymphocytic Leukemia
 Tara Leslie

  Lymphomas
  Alex Chan

 Fundamental 5B
 Lean Thinking with the
 Toyota Production System
 Shaun O'Connor

  Clinical 5C

  End of Life Care Discussion
  Session
  Peter Gilbar 

  Satellite Symposium - Merck
  Hospital Pharmacists Taking the Lead - How Can Guideline Based
  Standing Orders / Pathways Enhance Effective CINV Patient Care

  Panel: Developing to Established...How to Define Oncology Pharmacy as a Specialty

• Harbans Dhillon, University Malaya Medical Centre, Kuala Lumpur, Malaysia
• Tara Leslie, Alberta Health Services, Calgary, AB, Canada
• Annemeri Livinalli, Sociedade Brasileira de Farmacêuticos em Oncologia, Jundiai, Brazil
• Klaus Meier, Heidekreis-Klinikum GmbH, Soltau, Germany
• Shaun O'Connor, Box Hill Hospital (Eastern Health), Box Hill, VIC, Australia
• Rowena Schwartz, McKesson Specialty Health, Magnolia, TX, USA
• Kellie Jones Weddle, Purdue University, Indianapolis, IN, USA

  Clinical 6A
  Supportive Care
  Updates

  Alopecia 
  Milan J. Anadkat 

   Antibiotic Prophylaxis
  for Infections  
  Claudio González

  Clinical 6B
  Bone Marrow 
  Transplant Update
  Pablo Ramirez

  Role of the Clinical
  Pharmacist in a Stem
  Cell Transplantation Ward 
  Tiene Bauters     

Wednesday, April 20

  Panel: Global Impact of Cancer Care

• Alejandra Barahona, Chile
• Peter Gilbar, Australia
• Barry Goldspiel, USA​
• Klaus Meier, Germany
• Mario Jorge Sobreira da Silva, Brazil
• Shinya Suzuki, Japan
• Johan Vandenbroucke, Belgium
• Carien Van der merwe, South Africa
• Irene Weru, Kenya
• John Wiernikowski, Canada

  Clinical 7A
  Optimizing Care in the
  Older Adult with Cancer

  Rowena Schwartz, Annemeri Livinalli

 Research 7B 
 How Pharmacists Can Integrate
 Research into Daily Oncology Practice

 Judith Smith, Tiene Bauters, Rosalyn Sims

  Satellite Symposium - BD Medical 
  Mitigating Risk During Hazardous Drug Handling: Improving
  the Practice of Safe Handling of Hazardous Drugs

  Clinical 8A
  Application of
  Pharmacogenomics in
  Daily Clinical Practice

  Mario Chiong Lay

  Fundamental 8B
  Communicating Medical 
  and Oncology Information 
  to Health Care Professionals
  and Patients

  Twitter and Virtual Journal
  Club: Stay Up to Date with
  Distance Learning
  Felice Musicco

  Social Media in Oncology,
  Risk and Benefit
  Gustavo Espinoza
   

  Research 8C
  Interacting with
  Professional Journals: 
  Reviewing and Publishing

  Barry Goldspiel, Alex Chan

  Clinical 9A
  Gastrointestinal Tumors Update

  Jorge Gallardo

Fundamental 9B  
Dose Banding: Safety
and Savings in One

 Carole Chambers, 
 Johan Vandenbroucke

Fundamental 9C
Tools and Methods for
Pharmaceutical Care
Plans and Documentation

Klaus Meier 

Development and Implementation:
The Tools required by Clinical
Pharmacists to Conduct Safe
Chemotherapy
Shinya Suzuki 

  Closing Panel: Cultural Diversity and Awareness in Oncology

• Sara Aguayo, Hospital Base San José Osorno, Osorno, Chile
• Tiene Bauters, Ghent University Hospital, Ghent, Belgium
• Harbans Dhillon, University Malaya Medical Centre, Kuala Lumpur, Malaysia
• Peter Gilbar, Toowoomba Hospital, Toowoomba, QLD, Australia
• Kellie Jones Weddle, Purdue University, Indianapolis, IN, USA
• Shinya Suzuki, National Cancer Center Hospital East, Kashiwa, Japan
• John Wiernikowski, McMaster Children's Hospital, Hamilton, ON, Canada
• Rosalyn Sims, Children's Hospital of Michigan, Detroit, MI, USA